SEM RSI Chart
Last 7 days
2.9%
Last 30 days
25.4%
Last 90 days
26%
Trailing 12 Months
21.9%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 6.8B | 0 | 0 | 0 |
2023 | 6.4B | 6.5B | 6.6B | 6.7B |
2022 | 6.3B | 6.3B | 6.3B | 6.3B |
2021 | 5.7B | 6.0B | 6.1B | 6.2B |
2020 | 5.5B | 5.4B | 5.4B | 5.5B |
2019 | 5.2B | 5.2B | 5.3B | 5.5B |
2018 | 4.5B | 4.7B | 4.9B | 5.1B |
2017 | 4.3B | 4.3B | 4.3B | 0 |
2016 | 3.8B | 4.1B | 4.3B | 0 |
2015 | 3.1B | 3.2B | 3.5B | 0 |
2014 | 3.0B | 3.0B | 3.0B | 0 |
2013 | 3.0B | 3.0B | 3.0B | 3.0B |
2012 | 2.9B | 2.9B | 2.9B | 2.9B |
2011 | 2.5B | 2.6B | 2.7B | 2.8B |
2010 | 0 | 2.3B | 2.3B | 2.4B |
2009 | 0 | 0 | 0 | 2.2B |
Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index
Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>
Returns of $10,000 invested in:
Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224
Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
May 09, 2024 | ortenzio rocco a | gifted | - | - | -200,000 | vice chairman & co-founder |
May 09, 2024 | ortenzio rocco a | gifted | - | - | 200,000 | vice chairman & co-founder |
Apr 30, 2024 | scully thomas | acquired | - | - | 10,000 | - |
Apr 30, 2024 | chernow david s | acquired | - | - | 230,000 | president and ceo |
Apr 30, 2024 | jackson martin f | acquired | - | - | 138,000 | executive vice president |
Apr 30, 2024 | tavenner marilyn b | acquired | - | - | 10,000 | - |
Apr 30, 2024 | ely james s. iii | acquired | - | - | 10,000 | - |
Apr 30, 2024 | malatesta michael f | acquired | - | - | 75,000 | chief financial officer |
Apr 30, 2024 | saich john a. | acquired | - | - | 100,000 | executive vice president |
Which funds bought or sold SEM recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 15, 2024 | Voya Investment Management LLC | added | 424 | 17,706,800 | 20,797,600 | 0.02% |
May 15, 2024 | Alberta Investment Management Corp | unchanged | - | 238,070 | 1,079,370 | 0.01% |
May 15, 2024 | ICON ADVISERS INC/CO | unchanged | - | 490,924 | 2,342,720 | 0.51% |
May 15, 2024 | GOLDMAN SACHS GROUP INC | added | 19.69 | 5,984,580 | 17,157,800 | -% |
May 15, 2024 | PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | added | 5.17 | 20,474 | 79,083 | -% |
May 15, 2024 | Aquatic Capital Management LLC | reduced | -89.92 | -791,415 | 117,585 | -% |
May 15, 2024 | Steward Partners Investment Advisory, LLC | new | - | 7,899 | 7,899 | -% |
May 15, 2024 | AMUNDI | added | 36.81 | 135,433 | 493,184 | -% |
May 15, 2024 | CITADEL ADVISORS LLC | reduced | -85.34 | -3,071,430 | 711,299 | -% |
May 15, 2024 | Tower Research Capital LLC (TRC) | reduced | -95.96 | -694,687 | 38,019 | -% |
Unveiling Select Medical Holdings Corp's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Select Medical Holdings Corp)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
UNH | 479.9B | 379.5B | 31.24 | 1.26 | ||||
CI | 96.4B | 206.0B | 25.01 | 0.47 | ||||
HCA | 84.6B | 66.7B | 15.46 | 1.27 | ||||
CVS | 72.2B | 360.9B | 9.86 | 0.2 | ||||
CNC | 41.2B | 155.5B | 15.05 | 0.26 | ||||
UHS | 12.0B | 14.7B | 14.73 | 0.82 | ||||
DVA | 12.0B | 12.3B | 14.68 | 0.97 | ||||
MID-CAP | ||||||||
CHE | 8.6B | 2.3B | 30.33 | 3.75 | ||||
ACHC | 6.2B | 3.0B | -547.09 | 2.07 | ||||
AMEH | 2.3B | 1.5B | 36.93 | 1.59 | ||||
AMN | 2.2B | 3.5B | 15.61 | 0.64 | ||||
SMALL-CAP | ||||||||
ADUS | 1.8B | 1.1B | 27.49 | 1.66 | ||||
BKD | 1.4B | 3.0B | -7.82 | 0.45 | ||||
BEAT | 55.6M | - | -3.68 | - | ||||
AMS | 21.1M | 21.6M | 38.19 | 0.98 |
Select Medical Holdings Corp News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | 7.8% | 1,789 | 1,659 | 1,666 | 1,675 | 1,665 | 1,581 | 1,568 | 1,585 | 1,600 | 1,560 | 1,534 | 1,564 | 1,546 | 1,460 | 1,424 | 1,233 | 1,415 | 1,375 | 1,393 | 1,361 | 1,325 |
Costs and Expenses | 3.4% | 1,597 | 1,545 | 1,536 | 1,516 | 1,514 | 1,500 | 1,485 | 1,479 | 1,496 | 1,492 | 1,386 | 1,378 | 1,378 | 1,333 | 1,267 | 1,168 | 1,286 | 1,262 | 1,270 | 1,236 | 1,213 |
S&GA Expenses | -100.0% | - | 44.00 | 41.00 | 43.00 | 42.00 | 39.00 | 39.00 | 37.00 | 38.00 | 38.00 | 38.00 | 36.00 | 35.00 | 35.00 | 36.00 | 33.00 | 34.00 | 34.00 | 34.00 | 31.00 | 29.00 |
EBITDA Margin | 3.9% | 0.12* | 0.12* | 0.11* | 0.11* | 0.11* | 0.10* | 0.10* | 0.11* | 0.14* | 0.16* | 0.17* | 0.18* | - | - | - | - | - | - | - | - | - |
Interest Expenses | -0.1% | 51.00 | 51.00 | 50.00 | 49.00 | 49.00 | 47.00 | 45.00 | 41.00 | 36.00 | 34.00 | 34.00 | 34.00 | 34.00 | 36.00 | 34.00 | 37.00 | 46.00 | 44.00 | 54.00 | 51.00 | 51.00 |
Income Taxes | 207.7% | 36.00 | 12.00 | 16.00 | 29.00 | 26.00 | 9.00 | 16.00 | 20.00 | 18.00 | -8.64 | 28.00 | 66.00 | 45.00 | 35.00 | 32.00 | 23.00 | 22.00 | 12.00 | 13.00 | 21.00 | 18.00 |
Earnings Before Taxes | 108.6% | 154 | 74.00 | 77.00 | 121 | 111 | 46.00 | 54.00 | 86.00 | 74.00 | 58.00 | 128 | 262 | 182 | 137 | 136 | 91.00 | 92.00 | 55.00 | 57.00 | 81.00 | 72.00 |
EBT Margin | 9.0% | 0.06* | 0.06* | 0.05* | 0.05* | 0.05* | 0.04* | 0.04* | 0.06* | 0.08* | 0.10* | 0.12* | 0.12* | - | - | - | - | - | - | - | - | - |
Net Income | 109.4% | 97.00 | 46.00 | 48.00 | 78.00 | 71.00 | 28.00 | 27.00 | 55.00 | 49.00 | 50.00 | 77.00 | 165 | 111 | 77.00 | 77.00 | 52.00 | 53.00 | 32.00 | 31.00 | 45.00 | 41.00 |
Net Income Margin | 8.7% | 0.04* | 0.04* | 0.03* | 0.03* | 0.03* | 0.03* | 0.03* | 0.04* | 0.05* | 0.06* | 0.07* | 0.07* | - | - | - | - | - | - | - | - | - |
Free Cashflow | -137.2% | -66.69 | 179 | 116 | 235 | 51.00 | 13.00 | 94.00 | 172 | 6.00 | -60.75 | 99.00 | 123 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | 2.2% | 7,858 | 7,690 | 7,684 | 7,702 | 7,700 | 7,665 | 7,555 | 7,552 | 7,536 | 7,360 | 7,899 | 7,956 | 7,921 | 7,655 | 7,660 | 7,468 | 7,116 | 7,340 | 7,155 | 7,107 | 7,021 |
Current Assets | 14.5% | 1,440 | 1,258 | 1,276 | 1,304 | 1,314 | 1,271 | 1,217 | 1,221 | 1,251 | 1,139 | 1,779 | 1,868 | 1,835 | 1,594 | 1,624 | 1,363 | 998 | 1,213 | 1,050 | 1,028 | 1,053 |
Cash Equivalents | 10.3% | 93.00 | 84.00 | 77.00 | 101 | 84.00 | 98.00 | 108 | 95.00 | 131 | 74.00 | 748 | 803 | 750 | 577 | 640 | 510 | 73.00 | 336 | 136 | 124 | 148 |
Net PPE | 0.1% | 1,025 | 1,024 | 1,007 | 1,004 | 987 | 1,001 | 957 | 956 | 953 | 961 | 937 | 928 | 931 | 943 | 928 | 959 | 979 | 998 | 997 | 1,009 | 973 |
Goodwill | 0.1% | 3,517 | 3,513 | 3,505 | 3,486 | 3,485 | 3,484 | 3,479 | 3,476 | 3,465 | 3,449 | 3,400 | 3,391 | 3,390 | 3,379 | 3,369 | 3,391 | 3,391 | 3,392 | 3,383 | 3,385 | 3,324 |
Liabilities | 1.3% | 6,192 | 6,116 | 6,134 | 6,166 | 6,247 | 6,275 | 6,187 | 6,206 | 6,127 | 5,995 | 5,909 | 5,985 | 6,124 | 6,004 | 5,899 | 5,800 | 5,520 | 5,437 | 5,295 | 5,267 | 5,264 |
Current Liabilities | -5.1% | 1,184 | 1,248 | 1,166 | 1,188 | 1,186 | 1,155 | 1,197 | 1,242 | 1,189 | 1,273 | 1,326 | 1,409 | 1,540 | 1,438 | 1,345 | 1,256 | 844 | 914 | 870 | 853 | 885 |
Long Term Debt | 4.8% | 3,759 | 3,588 | 3,695 | 3,695 | 3,767 | 3,835 | 3,750 | 3,724 | 3,738 | 3,556 | 3,384 | 3,386 | 3,387 | 3,389 | - | - | - | 3,420 | 3,337 | 3,350 | 3,299 |
Shareholder's Equity | 27.1% | 1,638 | 1,288 | 1,268 | 1,502 | 1,418 | 1,122 | 1,335 | 1,304 | 1,367 | 1,326 | 1,364 | 1,450 | 1,351 | 1,253 | 1,219 | 1,172 | 975 | 929 | 906 | 996 | 925 |
Retained Earnings | 10.5% | 831 | 752 | 723 | 697 | 635 | 581 | 570 | 566 | 596 | 593 | 639 | 713 | 625 | 553 | 537 | 496 | 317 | 280 | 269 | 353 | 314 |
Additional Paid-In Capital | 2.4% | 505 | 493 | 482 | 474 | 462 | 452 | 445 | 442 | 490 | 504 | 502 | 516 | 514 | 509 | 501 | 497 | 492 | 491 | 485 | 493 | 488 |
Shares Outstanding | 0.0% | 128 | 128 | 128 | 127 | 127 | 127 | 127 | 126 | 132 | 134 | 134 | 135 | - | - | - | - | - | - | - | - | - |
Minority Interest | 4.2% | 270 | 259 | 256 | 256 | 248 | 235 | 229 | 232 | 229 | 216 | 218 | 216 | 205 | 192 | 180 | 180 | 166 | 158 | 151 | 150 | 123 |
Float | - | - | - | - | 3,254 | - | - | - | 2,361 | - | - | - | 4,692 | - | - | - | 1,574 | - | - | - | 1,705 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -137.2% | -66,689 | 179,442 | 116,338 | 234,838 | 51,440 | 12,544 | 94,263 | 171,681 | 6,337 | -60,752 | 98,954 | 123,138 | 239,888 | 207,438 | 134,537 | 642,014 | 44,084 | 178,542 | 133,726 | 91,152 | 41,762 |
Share Based Compensation | -1.8% | 11,610 | 11,818 | 11,483 | 10,327 | 10,181 | 9,799 | 10,187 | 8,946 | 8,823 | 8,938 | 8,194 | 7,099 | 6,709 | 6,422 | 6,962 | 6,963 | 6,903 | 7,020 | 6,818 | 6,358 | 6,255 |
Cashflow From Investing | 17.1% | -57,657 | -69,584 | -63,018 | -66,813 | -69,062 | -57,234 | -55,011 | -58,763 | -55,331 | -99,268 | -69,081 | -35,660 | -52,585 | -53,168 | 18,377 | -35,903 | -44,659 | -46,019 | -43,231 | -144,680 | -82,799 |
Cashflow From Financing | 228.7% | 132,960 | -103,292 | -77,047 | -150,561 | 3,419 | 34,373 | -25,698 | -149,130 | 105,565 | -513,653 | -85,383 | -34,259 | -14,090 | -217,009 | -22,851 | -169,537 | -262,144 | 67,396 | -78,568 | 29,749 | 13,674 |
Dividend Payments | -100.0% | - | 16,048 | 16,035 | 15,924 | 15,897 | 15,897 | 15,893 | 16,108 | 16,691 | 16,784 | 16,940 | 16,876 | - | - | - | - | - | - | - | - | - |
Buy Backs | -100.0% | - | 1,709 | 9,544 | 1,506 | - | 1,914 | 14,991 | 126,947 | 51,676 | 13,426 | 64,440 | 1,610 | - | 1,792 | 4,827 | 724 | 8,691 | 1,222 | 23,689 | 13,620 | - |
Condensed Consolidated Statements of Operations (unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Income Statement [Abstract] | ||
Revenue | $ 1,788,809 | $ 1,664,980 |
Costs and expenses: | ||
Cost of services, exclusive of depreciation and amortization | 1,494,610 | 1,418,819 |
General and administrative | 48,447 | 42,279 |
Depreciation and amortization | 54,069 | 52,425 |
Total costs and expenses | 1,597,126 | 1,513,523 |
Other operating income | 2,284 | 0 |
Income from operations | 193,967 | 151,457 |
Other income and expense: | ||
Equity in earnings of unconsolidated subsidiaries | 10,421 | 8,556 |
Interest expense | (50,763) | (48,571) |
Income before income taxes | 153,625 | 111,442 |
Income tax expense | 36,458 | 26,185 |
Net income | 117,167 | 85,257 |
Less: Net income attributable to non-controlling interests | 20,270 | 14,452 |
Net income attributable to Select Medical Holdings Corporation | $ 96,897 | $ 70,805 |
Earnings per common share (Note 13): | ||
Basic (in dollars per share) | $ 0.75 | $ 0.56 |
Diluted (in dollars per share) | $ 0.75 | $ 0.56 |
Condensed Consolidated Balance Sheets (unaudited) - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current Assets: | ||
Cash and cash equivalents | $ 92,620 | $ 84,006 |
Accounts receivable | 1,134,788 | 940,335 |
Prepaid income taxes | 9,034 | 22,726 |
Current portion of interest rate cap contract | 42,660 | 58,962 |
Other current assets | 161,238 | 151,617 |
Total Current Assets | 1,440,340 | 1,257,646 |
Operating lease right-of-use assets | 1,176,713 | 1,188,616 |
Property and equipment, net | 1,024,626 | 1,023,561 |
Goodwill | 3,517,071 | 3,513,170 |
Identifiable intangible assets, net | 324,125 | 329,916 |
Other assets | 375,388 | 376,722 |
Total Assets | 7,858,263 | 7,689,631 |
Current Liabilities: | ||
Overdrafts | 28,534 | 30,274 |
Current operating lease liabilities | 245,617 | 245,400 |
Current portion of long-term debt and notes payable | 60,184 | 70,329 |
Accounts payable | 163,551 | 174,312 |
Accrued and other liabilities | 686,491 | 728,150 |
Total Current Liabilities | 1,184,377 | 1,248,465 |
Non-current operating lease liabilities | 1,015,160 | 1,025,867 |
Long-term debt, net of current portion | 3,758,631 | 3,587,675 |
Non-current deferred tax liability | 133,987 | 143,306 |
Other non-current liabilities | 100,175 | 110,303 |
Total Liabilities | 6,192,330 | 6,115,616 |
Commitments and contingencies (Note 14) | ||
Redeemable non-controlling interests | 28,290 | 26,297 |
Stockholders’ Equity: | ||
Common stock, $0.001 par value, 700,000,000 shares authorized, 128,369,492 and 128,357,832 shares issued and outstanding at 2023 and 2024, respectively | 128 | 128 |
Capital in excess of par | 505,403 | 493,413 |
Retained earnings | 830,821 | 751,856 |
Accumulated other comprehensive income | 30,930 | 42,907 |
Total Stockholders’ Equity | 1,367,282 | 1,288,304 |
Non-controlling interests | 270,361 | 259,414 |
Total Equity | 1,637,643 | 1,547,718 |
Total Liabilities and Equity | $ 7,858,263 | $ 7,689,631 |